(300 days)
The Booker Box is passive connector, which allows connection to two defibrillators at a time to allow the physician to place a back up pair of electrodes. When the device is connected to two separate low energy defibrillators (using the adaptor/connectors compatible with the individual defibrillator) and disposable electrodes, energy from the defibrillator passes through the device to the external disposable electrodes. Should the physician need to the second set of electrodes are used as a back up in case the first pair configuration is unable to convert. The device also can be connected to a generic physiologic monitor recorder cable to allow unipolar recording using one of the back electrodes.
-
- Provides simultaneous connection to two defibrillators, which allows placement of a set of backup electrodes
- Provides connection to generic physiologic monitor recorder cable for unipolar recording from 2. using a back electrode.
- Used in Hospitals/EP Laboratories
-
- Used with manual defibrillators and has been tested with the following devices:
Hewlett Packard CodeMaster Hewlett Packard 7600, 7800 Zoll PD1200, PD1400, "M" Series Siemans 410 PhysioControl LifePak LP5, LP6, LP8, LP9, LP10 and LP 12
- Used with manual defibrillators and has been tested with the following devices:
The Booker Box is passive connector, which allows connection to two defibrillators at a time to allow the physician to place a back up pair of electrodes.
The provided text is a 510(k) premarket notification letter from the FDA regarding a medical device, the "Booker Box Defibrillation Cable Adapter, Model Pad 5001." This document primarily addresses the substantial equivalence determination for marketing the device and does not contain information about specific acceptance criteria, device performance studies, sample sizes, expert qualifications, or ground truth methodologies as typically expected for proving a device meets acceptance criteria in a detailed clinical or performance study report.
Therefore, I cannot extract the requested information from the provided text as it is not present in this type of regulatory correspondence. The letter confirms that the device is substantially equivalent to legally marketed predicate devices and can therefore be marketed. It does not elaborate on the specific performance data or studies that might have been submitted by the manufacturer to demonstrate this equivalence.
To answer your questions, I would need a different type of document, such as a summary of safety and effectiveness data (SSED), a clinical study report, or a performance testing report from the device manufacturer.
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States of America. The seal is circular and features the department's name around the perimeter. In the center is a stylized emblem of an eagle, which is a common symbol of the United States.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUL 2 0 2000
Mr. Byron Zahler TZ Medical Inc. 15858 SW Upper Boones Ferry Road Lake Oswego, OR 97035
K993205 Re: Booker Box Defibrillation Cable Adapter, Model Pad 5001 Regulatory Class: II (two) Product Code: 74 LDD, DSA March 18, 2000 Dated: Received: April 21, 2000
Dear Mr. Zahler:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to A substantially equivalent determination assumes compliance with 895. the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Please note: this response to your premarket Federal Register. notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
{1}------------------------------------------------
Page 2 - Mr. Bryon Zahler
This letter will allow you to begin marketing your device as described in inzo feecer wire are area. The FDA finding of substantial your brokk, premains a legally marketed predicate device results equivalence of your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation 11 you debiro opend additionally 809.10 for in vitro diagnostic (zi circ our over and add the Office of Compliance at (301) 594-4586. acviceb// produce on the promotion and advertising of your Additionally) to questions the office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on premained insibilities under the Act may be obtained from the Division of your responsibirers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
Buim E. Auseyom
James E. Dillard III Director Division of Cardiovascular and Respiratory Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
993205 510(k) Number (if known)
Device Name:
Booker Box Defibrillation Cable Adapter and Adapter/Connectors
Indications For Use:
The Booker Box is passive connector, which allows connection to two defibrillators at a time to allow the physician to place a back up pair of electrodes. When the device is connected to two separate low energy defibrillators (using the adaptor/connectors compatible with the individual defibrillator) and disposable electrodes, energy from the defibrillator passes through the device to the external disposable electrodes. Should the physician need to the second set of electrodes are used as a back up in case the first pair configuration is unable to convert. The device also can be connected to a generic physiologic monitor recorder cable to allow unipolar recording using one of the back electrodes.
-
- Provides simultaneous connection to two defibrillators, which allows placement of a set of backup electrodes
- Provides connection to generic physiologic monitor recorder cable for unipolar recording from 2. using a back electrode.
- ડે. Used in Hospitals/EP Laboratories
-
- Used with manual defibrillators and has been tested with the following devices:
Hewlett Packard CodeMaster Hewlett Packard 7600, 7800 Zoll PD1200, PD1400, "M" Series Siemans 410 PhysioControl LifePak LP5, LP6, LP8, LP9, LP10 and LP 12
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence Of CDRH, Office OF Device Evaluation (ODE)
E. D. Hanson
Cardiovascular, Respiratory, and Neurological Devices
510(k) Number
Over-The-Counter Use
(Optional Format 1-2-96)
Prescription Use (Per 21 CFR 801.109)
§ 870.5300 DC-defibrillator (including paddles).
(a)
Low-energy DC-defibrillator —(1)Identification. A low-energy DC-defibrillator is a device that delivers into a 50 ohm test load an electrical shock of a maximum of 360 joules of energy used for defibrillating (restoring normal heart rhythm) the atria or ventricles of the heart or to terminate other cardiac arrhythmias. This generic type of device includes low energy defibrillators with a maximum electrical output of less than 360 joules of energy that are used in pediatric defibrillation or in cardiac surgery. The device may either synchronize the shock with the proper phase of the electrocardiogram or may operate asynchronously. The device delivers the electrical shock through paddles placed either directly across the heart or on the surface of the body.(2)
Classification. Class II (performance standards).(b)
High-energy DC-defibrillator —(1)Identification. A high-energy DC-defibrillator is a device that delivers into a 50 ohm test load an electrical shock of greater than 360 joules of energy used for defibrillating the atria or ventricles of the heart or to terminate other cardiac arrhythmias. The device may either synchronize the shock with the proper phase of the electrocardiogram or may operate asynchronously. The device delivers the electrical shock through paddles placed either directly across the heart or on the surface of the body.(2)
Classification. Class III (premarket approval).(c)
Date PMA or notice of completion of a PDP is required. A PMA or a notice of completion of a PDP is required to be filed with the Food and Drug Administration on or before December 26, 1996 for any DC-defibrillator (including paddles) described in paragraph (b)(1) of this section that was in commercial distribution before May 28, 1976, or that has, on or before December 26, 1996 been found to be substantially equivalent to a DC-defibrillator (including paddles) described in paragraph (b)(1) of this section that was in commercial distribution before May 28, 1976. Any other DC-defibrillator (including paddles) described in paragraph (b)(1) of this section shall have an approved PMA or declared completed PDP in effect before being placed in commercial distribution.